Aristocort: Effective Topical Corticosteroid for Inflammatory Skin Conditions
| Product dosage: 4mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.96 | $57.62 (0%) | 🛒 Add to cart |
| 90 | $0.90 | $86.43 $80.84 (6%) | 🛒 Add to cart |
| 120 | $0.85 | $115.24 $102.34 (11%) | 🛒 Add to cart |
| 180 | $0.82 | $172.86 $147.06 (15%) | 🛒 Add to cart |
| 270 | $0.79
Best per pill | $259.29 $214.14 (17%) | 🛒 Add to cart |
Synonyms | |||
Aristocort (triamcinolone acetonide) is a mid-potency synthetic corticosteroid formulated for topical application to manage a wide spectrum of inflammatory and pruritic dermatoses. It functions by modulating inflammatory responses, reducing edema, erythema, and itching. This cream is a cornerstone in dermatological therapy, offering a balance of efficacy and tolerability for both acute flare-ups and chronic maintenance. Its vasoconstrictive and anti-proliferative properties make it a versatile agent in a clinician’s armamentarium.
Features
- Active ingredient: Triamcinolone acetonide (0.025%, 0.1%, 0.5% concentrations)
- Formulation: Topical cream, ointment, or lotion
- Pharmacologic class: Medium to high potency corticosteroid (Group 4-3, depending on concentration and vehicle)
- Mechanism: Binds to cytoplasmic glucocorticoid receptors, inhibiting the release of inflammatory mediators
- Presentation: Typically available in 15g, 30g, and 60g tubes or jars
Benefits
- Rapidly reduces inflammation, erythema, swelling, and pruritus associated with various dermatoses.
- Provides targeted therapy with minimal systemic absorption when used appropriately, enhancing local efficacy.
- Available in multiple potencies and formulations (cream, ointment, lotion) to suit different skin types, conditions, and body areas.
- Helps restore the skin’s barrier function by controlling the underlying inflammatory process.
- Can be used for short-term management of acute flares or, under strict medical supervision, for longer-term control of chronic conditions.
- Offers a proven safety and efficacy profile backed by decades of clinical use and dermatological research.
Common use
Aristocort is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. This includes, but is not limited to, atopic dermatitis (eczema), contact dermatitis (both allergic and irritant), seborrheic dermatitis, nummular eczema, lichen simplex chronicus, psoriasis (particularly in intertriginous areas or for thinner plaques), and discoid lupus erythematosus. It is also used off-label for conditions like lichen planus and certain granulomatous diseases. Selection of the appropriate potency (0.025%, 0.1%, or 0.5%) is contingent upon the severity of the condition, the anatomical site involved, and the patient’s age.
Dosage and direction
Apply a thin film of Aristocort to the affected area two to four times daily, as directed by a physician. The frequency of application often depends on the severity of the condition; severe cases may initiate with more frequent application, tapering to once-daily or less frequent application as symptoms improve. The amount needed varies with the size of the affected area; the “fingertip unit” (FTU) is a useful measure for guidance (one FTU, the amount from the tip to the first crease of an adult index finger, covers an area approximately twice the size of an adult flat hand). Gently rub in until the medication disappears. Occlusive dressings may be used for severe or recalcitrant conditions to enhance penetration but must only be employed under direct medical supervision due to a significantly increased risk of systemic absorption and local adverse effects. Treatment should not be continued for prolonged periods without reevaluation by a healthcare provider.
Precautions
For external use only. Avoid contact with the eyes, lips, and other mucous membranes. Do not use on areas of the skin with pre-existing atrophy. Use with caution on the face, groin, and axillae due to higher absorption rates and increased risk of skin atrophy, striae, and telangiectasia. Do not apply to large surface areas, under occlusive dressings for extended periods, or to denuded or exuding skin without specific medical instruction, as these practices can promote significant systemic absorption leading to reversible HPA axis suppression, manifestations of Cushing’s syndrome, hyperglycemia, and glucosuria. Discontinuation of the drug should be gradual after long-term therapy. If irritation or sensitization develops, treatment should be discontinued and appropriate therapy instituted. The safety and efficacy of Aristocort in pediatric patients under 2 years of age have not been established; use in children should be limited to the minimal amount consistent with favorable results, as children are more susceptible to systemic toxicity.
Contraindications
Aristocort is contraindicated in patients with a history of hypersensitivity to triamcinolone acetonide, any other corticosteroids, or any component of the formulation. It is contraindicated for the treatment of rosacea, perioral dermatitis, acne vulgaris, and cutaneous infections caused by fungi (e.g., candidiasis, tinea corporis/cruris/pedis) or viruses (e.g., herpes simplex, vaccinia, varicella). Do not use on untreated bacterial or parasitic skin infections.
Possible side effect
The most common side effects are local and include burning, itching, irritation, dryness, folliculitis, hypertrichosis, and acneiform eruptions. With prolonged use or use under occlusion, the following may occur: skin atrophy, striae, telangiectasia, hypopigmentation, miliaria, and secondary infection. Less commonly, allergic contact dermatitis may develop. Systemic absorption can lead to reversible hypothalamic-pituitary-adrenal (HPA) axis suppression, Cushing’s syndrome, hyperglycemia, and glaucoma (particularly with periocular use), especially with use on large surface areas, prolonged use, or use under occlusion.
Drug interaction
Formal topical drug interaction studies have not been conducted with Aristocort. However, because of the potential for systemic absorption, interactions similar to those seen with systemic corticosteroids may occur. Caution is advised when used concomitantly with other drugs that inhibit CYP3A4 enzymes (e.g., ketoconazole, itraconazole, clarithromycin), as this may increase the risk of systemic corticosteroid effects. No known interactions with topical agents applied sequentially exist, but a time interval between applications of different products is generally recommended.
Missed dose
If a dose is missed, apply it as soon as remembered. However, if it is almost time for the next scheduled dose, skip the missed dose and resume the usual dosing schedule. Do not apply a double dose to make up for a missed one.
Overdose
Topically applied Aristocort can be absorbed in sufficient amounts to produce systemic effects. Acute overdose is unlikely from topical application. Chronic overdose or misuse (e.g., application to large areas, long duration, use under occlusion) can lead to systemic corticosteroid effects such as hypercorticism and adrenal suppression. There is no specific antidote. Treatment involves discontinuation of the drug and supportive, symptomatic management. In cases of significant HPA axis suppression, systemic corticosteroid replacement therapy may be necessary until adrenal function recovers.
Storage
Store at controlled room temperature, 20°C to 25°C (68°F to 77°F). Excursions are permitted between 15°C and 30°C (59°F and 86°F). Keep the tube or jar tightly closed. Do not freeze. Keep out of reach of children and pets. Discard any medication that is outdated or no longer needed.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here.
Reviews
- “As a dermatologist with over twenty years of practice, Aristocort 0.1% cream remains a reliable workhorse for managing moderate eczematous dermatitis. Its efficacy in reducing inflammation and pruritus is consistently observed, and patient tolerance is generally excellent when used as directed for appropriate durations.” – Dr. E. Lawson, MD, Dermatology
- “I’ve prescribed Aristocort for my patients with chronic lichen simplex for years. The 0.025% strength is often sufficient for maintenance therapy on thicker skin, minimizing the risk of side effects while providing adequate symptomatic control. It’s a predictable and effective agent.” – Physician Assistant, Dermatology
- “After struggling with severe contact dermatitis from a new detergent, my dermatologist prescribed Aristocort 0.1% ointment. The itching subsided within two days, and the redness and scaling improved dramatically over a week. I was instructed to use it for only two weeks, which was effective and prevented rebound.” – Patient Review
- “In our pediatric dermatology clinic, we use the lowest effective potency of Aristocort for the shortest duration possible. For older children with stubborn patches of atopic dermatitis, it can be very effective, but parental education on proper amount and duration is paramount to its safe use.” – Pediatric Nurse Practitioner